The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective double-blind, randomized, parallel-group, placebo-controlled trial
designed to examine the effect of supplementation with 50,000 IU vitamin D3 for 3 months on
Polycystic Ovary Syndrome (PCOS) prognosis, serum 25-Hydroxy Vitamin D (25(OH)D) level, serum
chromium level, insulin resistance, and Body Mass Index (BMI), in 60 overweight Jordanian
female patients diagnosed with PCOS and with hypovitaminosis D.
Phase:
Phase 3
Details
Lead Sponsor:
Hayat Pharmaceutical Co. PLC
Collaborator:
Jordan University of Science and Technology
Treatments:
Cholecalciferol Chromium Ergocalciferols Vitamin D Vitamins